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Abstract
The rare recessive developmental disorder Trichothiodystrophy (TTD) is characterized by brittle hair and nails. Patients also
present a variable set of poorly explained additional clinical features, including ichthyosis, impaired intelligence,
developmental delay and anemia. About half of TTD patients are photosensitive due to inherited defects in the DNA repair
and transcription factor II H (TFIIH). The pathophysiological contributions of unrepaired DNA lesions and impaired
transcription have not been dissected yet. Here, we functionally characterize the consequence of a homozygous missense
mutation in the general transcription factor II E, subunit 2 (GTF2E2/TFIIEb) of two unrelated non-photosensitive TTD (NPS-
TTD) families. We demonstrate that mutant TFIIEb strongly reduces the total amount of the entire TFIIE complex, with a
remarkable temperature-sensitive transcription defect, which strikingly correlates with the phenotypic aggravation of key
clinical symptoms after episodes of high fever. We performed induced pluripotent stem (iPS) cell reprogramming of patient fi-
broblasts followed by in vitro erythroid differentiation to translate the intriguing molecular defect to phenotypic expression in
relevant tissue, to disclose the molecular basis for some specific TTD features. We observed a clear hematopoietic defect
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during late-stage differentiation associated with hemoglobin subunit imbalance. These new findings of a DNA repair-
independent transcription defect and tissue-specific malfunctioning provide novel mechanistic insight into the etiology of
TTD.
Introduction
Trichothiodystrophy (TTD) is a rare recessive disorder, charac-
terized by brittle hair and nails, due to a low content of sulfur-
rich proteins in keratinocytes. Patients present a variable
combination of additional symptoms including, ichthyosis,
impaired intelligence, decreased fertility, microcephaly, de-
velopmental delay, anemia and progeroid features (1).
Approximately, 50% of the TTD patients are sun(photo)-
sensitive, caused by mutations in the xeroderma pigmentosum
group B (XPB/ERCC3), group D (XPD/ERCC2) or trichothiodystro-
phy group A (TTDA/GTF2H5) genes (2,3), each encoding for sub-
units of the transcription factor IIH (TFIIH) (4). In addition to an
essential role of TFIIH in transcription initiation, this complex is
also pivotal for nucleotide excision repair (NER). These muta-
tions impair NER, which is the only DNA repair system in mam-
mals capable of removing sun-induced DNA damage and thus
easily explain photo-sensitivity. The additional features are
thought to be derived by subtle defects in the transcription
function of TFIIH.
We previously proposed that reduced stability of mutant
TFIIH in TTD patients may cause some of the TTD-specific clini-
cal features, which are mainly apparent in terminally differenti-
ated tissues (3). Within late-stage differentiated cells, the
majority of genes become transcriptionally silenced, including
genes encoding for basal transcription factors such as TFIIH.
The amount of proteins encoded by transcriptionally “switched
off” genes in these cells thus depends on the stability of their re-
sidual mRNAs and proteins produced at prior stages. We have
shown that TTD-causing mutations in TFIIH genes affect the
stability of the entire complex and that the steady-state level of
each subunit becomes strongly reduced (2,5,6). In cultured fibro-
blast, this reduced amount appeared sufficient to provide nor-
mal transcription levels. However, at the final stages of cellular
differentiation when de novo synthesis is switched off, the re-
duced TFIIH stability in TTD cells may result in too low amounts
of TFIIH to support sufficient transcription of tissue-specific pro-
teins. The observed reduced transcription of the SPRR2 gene in
terminally differentiated keratinocytes from a TTD-mimicking
mouse-model (7) supported this hypothesis. SPRR2 is a sulfur-
rich matrix protein, only expressed at very late stages of differ-
entiation, which crosslinks keratin filaments to provide me-
chanical strength to skin and hair cells. In terminally
differentiated red blood cells, TTD-specific TFIIH mutations
may cause imbalanced globin mRNA expression, explaining the
relatively frequent anemic features of TTD (1,8). It is however
not excluded that unrepaired (endogenously produced) DNA le-
sions in transcription units, as a consequence of the DNA repair
defect associated with mutated TFIIH, may also contribute to re-
duced transcription in late-stage differentiated cells. Indeed, en-
dogenous metabolic stress and environmental cues do generate
a variety of DNA lesions, which may play a role in the pathogen-
esis of accelerating aging (9) and other degenerative diseases
(10,11).
We hypothesize that a large of part of the clinical features
associated with repair-proficient non-photosensitive TTD (NPS-
TTD) are based on gene expression defects (12). In only a minor-
ity of NPS-TTD patients causative mutations were found in
genes encoding for the M-phase-specific PLK1 interacting pro-
tein (MPLKIP/TTDN1) (13) or the b subunit of the transcription
factor IIE (GTF2E2/TFIIEb) (14) and in an isolated case in the
RNF113A gene (15). Nevertheless, thus far no obvious experi-
mental evidence for transcription malfunctioning in NPS-TTD
patient cells has been provided. Here, we present the genetic
and functional analysis of NPS-TTD cases with homozygous
GTF2E2 mutations. We showed that fibroblasts derived from
these patients exhibit a clear transcription defect, however only
when cultured at elevated temperatures. We used induced plu-
ripotent stem cell (iPS) reprogramming of patient fibroblasts fol-
lowed by in vitro erythroid differentiation to show hemoglobin
protein imbalance in late-stage differentiated erythroid cells, in
line with patients’ anemic features.
Results
Genetic analysis of non-photosensitive TTD patients
Recently, two unrelated NPS-TTD patients were identified with
different mutations in the gene encoding for the beta subunit of
transcription initiation factor II E (TFIIEb/GF2E2) (14), suggesting
impaired transcription in these patients. To provide functional
evidence for affected transcription in NPS-TTD, we first per-
formed genetic analyses among a selected group of NPS-TTD
patients to identify possible other mutations in transcription
factors.
Patient TTD218UT is of Moroccan origin and was born to
consanguineous parents. She was referred to the clinical geneti-
cist at 1.5 years of age with brittle hair (low cysteine content and
tiger-tail banding pattern), ichthyosis, microcephaly (2.5 SD),
psychomotor retardation, short stature (2.5 SD) and microcytic
anemia. She showed recurrent aggravation of hair-loss by tufted
breakage at the scalp boundary immediately following episodes
of infection-induced fever. Also upon long-term exposure to the
heat of the sun, she appears to have increased hair-loss. At the
age of 8 years, she shows no signs of progressive deterioration.
She has a happy and friendly personality with an IQ of 54 (at
7 years of age). She has a limited physical endurance.
Laboratory investigation revealed microcytic hypochromic ane-
mia (Hb 6.5) without sequence anomalies nor deletions or dupli-
cations of the genes encoding for the alpha or beta globin
chains (not shown). We performed whole genome sequencing
on patient’s DNA, using the sequencing-by-ligation method
from Complete Genomics (16,17). Surprisingly, we identified a
homozygous variant in the GTF2E2/TFIIEb gene, creating a mis-
sense mutation (c.C559T [p.Asp187Tyr]). This mutation is identi-
cal to one of the mutations in GTF2E2/TFIIEb previously
described by Kuschal et al. (14). Its homozygous presence was
confirmed by Sanger sequencing of cDNA generated from pa-
tient’s cells and found to co-segregate with the phenotype
within the family (Fig. 1A and B).
Additional Sanger sequencing of the TFIIE subunits among
another group of selected NPS-TTD patients revealed the identi-
fication of the same homozygous mutation (c.G559T in GTF2E2/
TFIIEb) in two sibs, TTD241HE and TTD275HE. These patients
are born to consanguineous parents of Moroccan origin, which
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are both heterozygous for this mutation (Fig. 1C) and are not re-
lated to patient TTD218UT. Patient TTD241HE was diagnosed at
18 months of age with brittle hair (tiger-tail banding pattern),
dysmorphic features, developmental delay, moderate intellec-
tual disability, microcephaly, difficulty swallowing and failure
to thrive, cheerful character, mild Ichthyosis, growth retarda-
tion (length 4.7 SD, weight 2.6 SD), occipitofrontal circumfer-
ence (OFC) (3.1 SD), hypertonia, microcytic hypochromic
anemia and recurrent infections. At 6 years of age, she still
showed spasticity, ataxia and mild cognitive retardation
Figure 1. TFIIE protein levels and stability is reduced in TFIIEb-mutated TTD cells. (A) Sanger sequencing profiles of TFIIEb cDNA. TTD218UT shows homozygosity for
the c.G559T missense mutation. (B,C) TFIIEb mutations segregating in the patients’ families. (D–F) Immuno-fluorescence analysis of TTD218UT and TTD251HE fibro-
blasts compared with wild-type control (C5RO) cells, stained for (D) TFIIEb, (E) TFIIEa or (F) XPB (TFIIH) and DNA was stained with DAPI (blue). Quantification of the
mean intensities (n¼50 nuclei), expressed as percentage of the mean intensity in normal cells, is shown beneath the representative images. Error bars indicate SEM.
(G) Immuno-blot analysis to determine protein stability of TFIIEb after cycloheximide (100 mM) treatment (for indicated times in hours) of Sv40-immoratlized patient
cells (TTD218UT_sv) compared with two wild-type controls (MRC5_sv, C5RO-sv). (H) Quantification of TFIIEb band intensities normalized to tubulin were expressed as
percentages of t¼0 values.
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without significant speech, but no signs of progressive deterio-
ration. She has one affected younger sib (TTD275HE), also diag-
nosed with brittle hair, dysmorphic features, mild
developmental delay, microcephaly, mild difficulty swallowing,
no failure to thrive, cheerful character, mild ichthyosis, addi-
tional left thumb, no recurrent infections and growth retarda-
tion were noticed.
Functional analysis of DNA repair capacity
We consider this TFIIEb mutation as likely causative for some of
the NPS-TTD patients, in line with our hypothesis that one of
the prime causes for this form of TTD is based on subtle tran-
scriptional defects. Since TFIIE is closely associated with TFIIH’s
transcription function (18,19), it is not excluded that mutant
TFIIE may influence TFIIH’s repair function. To that aim, we
thoroughly examined the cellular NER capacity in fibroblasts of
patient TTD218UT and TTD241HE. Patients’ fibroblast were not
hypersensitive to UV-light and exhibited proficient unscheduled
DNA repair synthesis (UDS) and recovery of RNA synthesis after
UV irradiation (RRS), indicating that both global-genome and
transcription-coupled NER are not affected (Supplementary
Material, Figs S1 and S2).
TFIIE protein levels and stability
The general transcription factor TFIIE consists of two subunits;
GTF2E1/TFIIEa and GTF2E2/TFIIEb (20–22) and is a crucial com-
ponent of the transcription preinitiation complex required for
transcription initiation and promoter opening by facilitating
loading and stable binding of TFIIH (18,23,24). Since TTD-
causing mutations in TFIIH destabilize the entire complex (25)
and because this frail TFIIH was suggested to cause TTD-
specific transcription features (3), we wondered whether also
this TFIIEb mutation affects TFIIE stability. Immuno-
fluorescence analysis showed that the steady-state levels of
TFIIEb and TFIIEa were strongly reduced to approximately 20
and 60%, respectively, of TFIIE levels in wild-type cells assayed
in parallel. Whereas the levels of TFIIH (assessed with anti-XPB
antibody) appeared unaffected, as expected (Fig. 1D–F,
Supplementary Material, Fig. S3A–C).
Immuno-blot analysis of cell-free extracts confirmed the low
steady-state levels of both TFIIE subunits (Supplementary
Material, Fig. S3D–E). Since quantitative RT-PCR showed that
the mRNA levels of both TFIIE subunits were unaffected (data
not shown), it is likely that the reduced TFIIE levels are derived
from protein instability. Western blot analysis on protein ex-
tracts isolated from cells incubated for different times in the
presence of the translation inhibitor cycloheximide showed a
strongly reduced stability of mutated TFIIEß, as compared with
wild-type TFIIEß (Fig. 1G and H). The levels of both subunits can
be fully restored by reintroducing wild-type TFIIEb cDNA in the
patient cells (Supplementary Material, Fig. S4). Together, these
data show that the single amino-acid substitution p.Asp187Tyr
in the beta subunit of TFIIE causes instability of the entire
complex.
Transcription levels
It is to be expected that with such a severe reduction of the cel-
lular content of TFIIE, the overall transcription would be im-
paired. Moreover, previous studies (26) have shown that amino
acid substitutions p.Ile171Ser and p.Ile189Ser, both in close
proximity of patient’s TFIIEb mutation (c.G559T [p.Asp187Tyr]),
affect XPB helicase activity and severely reduce transcriptional
capacity in cell-free in vitro assays. Surprisingly however, basal
transcription levels, assayed by ethynyl uridine (EU) pulse label-
ing, were not affected in patient cells under standard culture
conditions (Fig. 2A and B, Supplementary Material, Fig. S5A and
B). Despite the strong reduction in steady-state levels of TFIIE,
the remaining amount is apparently sufficient to support nor-
mal levels of transcription. Therefore, we searched for experi-
mental conditions in which TFIIE levels may become limiting to
transcription. We became aware that upon recurrent infections
patient TTD218UT experiences reversible fever-dependent
worsening of her brittle hair phenotype, most likely due to a fur-
ther decrease or inactivation of the already low amounts of mu-
tant TFIIE. Recurrent infections have also been reported for
patient TTD241HE, however, fever-dependent worsening of any
clinical feature could not be confirmed. Previously, we have
found that a specific TTD-causative mutation in XPD (c.C2050T
[p.Arg658Cys]) causes thermo-lability of the entire TFIIH com-
plex, which was also accompanied by fever-dependent worsen-
ing of the TTD-specific hair phenotype in these patients (6).
Incubation of cells derived from these XPD-TTD patients at ele-
vated temperature showed a strong temperature-dependent re-
duction of transcription and severely reduced viability of the
cells. Upon culturing of TFIIEb-mutated TTD218UT and
TTD241HE cells for 3 days at 40 C, we observed a strikingly re-
duced transcription as compared with normal cells exposed to
the same temperature (Fig. 2A and B, Supplementary Material,
Fig. S5A and B).
To determine the effect of prolonged exposure to elevated
temperatures, we performed a colony survival assay on patient-
derived cells that were incubated for 12 days at 40 C. This ex-
tended culturing at higher temperature induced a dramatic
reduction in colony-forming ability of the TTD218UT cells com-
pared with control cells (Fig. 2C and D). The chronic exposure to
higher temperatures likely depletes TFIIE levels to such an ex-
tent that they become too low to allow sufficient transcription
to support cellular survival.
Erythroid differentiation of human iPS cells
Proliferating cultured fibroblasts are likely not representative to
mimic the in vivo conditions that determine the TTD-specific
symptoms, particularly since these are mainly apparent in ter-
minally differentiated tissues, such as hair-follicles (brittle
hair), epidermal keratinocytes (ichthyosis), neurons (impaired
neurologic functions) and erythrocytes (anemia). Patients har-
boring a TFIIEb mutation present microcytic anemia [this study
and (14)], characterized by a reduced mean cell volume (MCV),
which might be the consequence of reduced iron binding or a
defect in late-stage erythroid differentiation driven by tran-
scriptional problems.
To recapitulate the TTD-phenotype in this patient, induced
pluripotent stem (iPS) cells may offer a powerful platform to in-
vestigate genotype–phenotype relationship in relevant tissue.
To this aim, we established an iPS clone reprogrammed from
TTD218UT primary fibroblasts, and two control iPS cell lines ob-
tained from healthy individuals, one reprogrammed from pri-
mary fibroblasts and one reprogrammed from a blood sample.
Isolated iPS clones were selected on the basis of normal karyo-
types, and thoroughly screened for expression of pluripotency
markers (e.g. OCT4, Nanog) and absence of expression of differ-
entiation markers (e.g. GFAP, AFP) (27), all of which were normal
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(data not shown). To investigate whether the TFIIEb mutation
could account for hematological malfunctions, we used a two-
phased liquid culture system, including an expansion and a dif-
ferentiation phase (28). Wild type and patient iPS cells were
similar in their ability to differentiate into a homogenous popu-
lation of CD71þ/CD235þ erythroblasts (Supplementary Material,
Fig. S7). Also, the cumulative and relative number of erythroid
cells generated during the expansion phase, prior to erythroid
differentiation, did not differ (data not shown), suggesting that
proliferation is not affected. Comparing erythroblast differentia-
tion at 37 C and a fever-mimicking temperature of 39 C indi-
cated that differentiation to CD71þ/CD235þ erythroblasts was
still similar among all iPS-derived erythroblasts (Supplementary
Material, Fig. S7). However, the cell size and number of multinu-
clear erythroblasts were increased in terminally differentiated
TTD-erythroblasts, which were even more affected at 39 C
(Fig. 3A–C, Supplementary Material, Fig. S6). Flow cytometric
analysis revealed an increase of cells with high forward and/or
side scatter of TTD-derived erythroid cells at 37 C compared
with control cells (Fig. 3C), suggesting defective cytokinesis and
cell size control, two important aspects heavily controlled dur-
ing erythropoiesis (29). Several TTD patients have microcytic
hypochromic anemia, which may suggest a disturbed hemoglo-
bin synthesis. Hemoglobin consists of two subunits from the al-
pha locus and two subunits from the beta locus. The beta locus
produces b and d subunits for adult HbA and HbA2, respectively,
c1 and c2 for fetal HbF1 and HbF2, and e for embryonal HbE.
Subunit imbalance can present as microcytic hypochromic ane-
mias and thalassemia-like phenotypes (30), as observed among
TTD patients without additional mutations in globin subunits
(8). Hemoglobins cannot be compared between adult erythro-
cytes and iPS-derived mature erythroblasts because iPS-derived
cells execute an embryonic/fetal program. However iPS-derived
cells can be compared among each other. HPLC analysis (31) of
iPS-derived erythroid cells showed reduced levels of HbF, HbA2
and HbE in TTD cells, with increased hemoglobin H (HbH/barts;
tetramers of beta locus globins only) (Fig. 3D, Supplementary
Material, Fig. S8). This may indicate an underproduction of al-
pha globin chains in TTD cells causing increased tetrameriza-
tion of c globin or b globin chains and reduced HbF, HbA2 and
HbE. Control cells primarily express HBF2, and low levels of
HBF1, contrary to TTD cells that express significantly higher lev-
els of HBF1 with a concomitant reduction of HBF2. These results
suggest a disturbed hemoglobin regulation during erythropoie-
sis in TTD iPS-derived erythroid cells. Reduced stability and
functionality of TFIIE in TTD may lead to reduced expression of
specific high abundant mRNAs e.g. the globin genes during ery-
throid differentiation. We suggest that in TTD patient-derived
iPS cells the beta locus generates several subtypes of globin
polypeptides, which cannot be matched by the reduced expres-
sion of the a-chain from the alpha locus, resulting in HbH for-
mation, anemia and microcytic hypochromic erythrocytes.
Discussion
We have identified a homozygous missense mutation (c.G559T
[p.Asp187Tyr]) in the beta subunit of TFIIE (GTF2E2/TFIIEb)
(Fig. 1A–C) in two non-related families of Moroccan origin with
Figure 2. Transcription and cell survival is reduced at 40 C in TFIIEb-mutated TTD cells. (A) Transcription levels after incubation for 72 h at 37 C or 40 C, measured by
pulse-labeling with ethynyl-uridine (EU) and subsequent fluorescent staining of incorporated EU, of Sv40-immortalized patient cells (TTD218UT_sv), compared with
wild-type controls (MRC5_sv, C5RO-sv). DNA was stained with DAPI (blue). (B) Quantification of the mean intensities (n¼ 50), expressed as percentages of intensity in
MRC5_sv. Error bars indicate SEM. (C,D) Coomassie staining and quantification of colonies (D) of TTD218UT_sv, MRC5_sv and C5RO-sv cells formed after 12 days cultur-
ing at 37 C (blue bars) or 40 C (red bars) (n¼2).
4693Human Molecular Genetics, 2017, Vol. 26, No. 23 |
Downloaded from https://academic.oup.com/hmg/article-abstract/26/23/4689/4110402
by Erasmus University Rotterdam user
on 27 February 2018
non-photosensitive TTD (NPS-TTD). This same mutation was
earlier identified as causative for NPS-TTD in another non-
related Moroccan NPS-TTD patient (14). In addition, in the same
study by Kuschal et al. another homozygous missense mutation
in TFIIEb (c.448 G>C [p.Ala150Pro]) was identified in one NPS-
TTD patient from Asian origin. Together, these TFIIEb mutations
in four non-related families firmly establish a causative genetic
relationship between mutated TFIIEb and NPS-TTD.
Figure 3. Affected Hematopoiesis in iPS-derived erythroid cells of TTD patients. In vitro erythroblast differentiation performed on iPS cells derived from TTD218UT
(TTD) fibroblasts, control fibroblasts (control F) and peripheral blood mononuclear cell derived erythroblasts (control E).(A) Cytospins and Giemsa-Gru¨nwald staining of
in vitro differentiated erythroblasts. Arrows indicate multinucleated cells. (B) Quantification of multinucleated cells, expressed as a percentage of total cells [>500 cells,
counted by two independent researchers (N¼2)]. (C) Dot plots of flow-cytometric analysis of differentiated erythroid control and TTD cells. Lower bar graph depicts the
quantification of the gated dot-plots [Q8¼FSClow/SSClow (normal size and intracellular structures); Q5¼FSChigh/SSClow (bigger cells); Q6¼FSChigh/SSChigh (bigger cells,
more intracellular structures); Q7¼FSClow/SSChigh (normal size, more intracellular structure); N¼5 for each. Error bars represent standard deviation] (D) HPLC analysis
of different hemoglobin variants. Bar graphs depict the percentage of hemoglobin variants: “HbF total” ¼ sum of HbF1 and HbF2, Hb-HbH ¼ sum of all non-aberrant he-
moglobin variants, HbA2, HbE, HbH represent the peaks identified as HbH, probably representing HbBarts (beta tetramers or gamma tetramers respectively) and “Hb
Total” ¼ sum of all the peaks. Experiments represent an N¼3 for TTD and N¼ 6 for control iPS-derived erythroid cells. Error bars represent standard deviation and stu-
dent t-test was performed to calculate significance, * <0.05 and ***< 0.01.
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We further noticed that this mutation in TFIIEb [c.G559T
(p.Asp178Tyr)] causes a severe reduction in the cellular amount
of this protein (Fig. 1D). Strikingly, also the alpha subunit of
TFIIE (TFIIEa) appeared significantly reduced by the mutation in
the beta subunit (Fig. 1E), eventually leading to a strong reduc-
tion of the entire two-subunit TFIIE complex in cultured cells of
these patients. Since this amino acid substitution is in close
proximity of the predicted interaction-site of TFIIEb with the
winged-helix domain of TFIIEa (32), it is anticipated to compro-
mise complex formation, which may explain the observed fra-
gility of the entire complex. In addition, it is likely that a
mutation causing instability of one subunit renders the entire
complex unstable, as previously found for other protein com-
plexes, including TTD-causing mutations of TFIIH (5,25).
Strikingly, however, this decline in the amount of an essen-
tial transcription initiation factor did not result in a measurable
effect on the overall transcription when cells were grown under
standard optimal culturing conditions (Fig. 2A). Only under spe-
cific conditions, i.e. incubation at elevated temperatures (Fig.
2B) or terminal differentiation (Fig. 3), we were able to observe
phenotypic consequences of this hypomorphic GTF2E2/TIIEb al-
lele. This fever-dependent worsening of clinical symptoms is
apparently not solely dependent on the pathogenic mutation,
since this peculiar phenotype was not clinically confirmed in
patients TTD241HE and TTD275HE. This apparent discrepancy
could be explained by an incomplete or reduced penetrance of
the disease-causing allele. Also, the patient’s body temperature
might not always reach the critical height and duration to ob-
serve worsening of TTD-specific features, which is off course
much better controlled within a cellular in vitro assay. We previ-
ously reported on a similar thermo-sensitive TTD-causing mu-
tation in the XPD subunit of TFIIH (6) that is also associated
with fever-dependent aggravation of TTD-specific features.
Hyperthermia generally causes partial denaturation of cellular
proteins and may affect protein complex formation. We thus
envisage that fever-driven hyperthermia will further reduce the
already compromised, mutation-derived, protein stability of
TFIIE complexes in TTD patient cells. The number of available
TFIIE complexes will thus decline to such an extent that eventu-
ally transcription will be affected. The consistent presence of
presumably hypomorphic variants in these TTD patients is ex-
pected, since general transcription factors, such as TFIIE, are
highly conserved and essential proteins in mammals, so fully
inactivating mutations (nonsense, frame-shift) are likely not
tolerated. Similarly, all reported cases with TFIIH mutations, in-
cluding the TTD-causative ones, carry at least one hypomorphic
allele (33). This is in line with previous reports that complete ab-
lation of the TFIIH subunits XPB and XPD in mice (Xpb/ or
Xpd/) resulted in very early embryonic lethality already at the
two cell stage (34,35).
Until recently, it appeared rather difficult to extrapolate
TTD-causing mutations to disease-specific phenotypic expres-
sion through available cellular and biochemical assays.
However, with the here applied iPS reprogramming of patient-
derived fibroblasts to stem cell-like cells and the subsequent in
vitro differentiation into erythroid progenitors we were now
able to show such a correlation. The observed disturbance of
the delicate balance of hemoglobin-forming polypeptide pro-
duction in late-stage erythroid progenitors underscores our hy-
pothesis that at least part of the TTD-specific features are a
consequence of affected transcription. It is further important to
note that transcriptional defects associated with TTD mutations
are mainly instigated by a stability problem of either TFIIE (this
paper) or TFIIH (5,25), rather than a direct failure in
transcription initiation. Hence, we speculate that fragility-
causing mutations in other basal factors required for gene-
expression, i.e. transcription-maturation, splicing [shown re-
cently for mutations within RNF113A (36)] or even protein trans-
lation may result in TTD-like diseases. It is thus important to
further investigate possible gene-expression functions of other
identified genes (e.g. MPLKIP/TTDN1) and not-yet-identified
NPS-TTD causing genes.
Materials and Methods
Massive parallel sequencing
Massive parallel sequencing (software version 2.5.0.37) was
done as described previously (16). Briefly, the human genome
sequencing procedures include DNA library construction, DNA
Nano-Ball (DNB) generation, DNB array self-assembling, cPAL-
based sequencing and imaging. Image data analyses including
base calling, DNB mapping, and sequence assembly. Reads were
mapped to the National Center for Biotechnology Information
(NCBI) reference genome, build 37. Variants were annotated us-
ing NCBI build 37 and dbSNP build 137. Data were provided as
lists of sequence variants (SNPs and short indels) relative to the
reference genome. Analysis of the massive parallel sequencing
data was performed using Complete Genomics analysis tools
(cga tools version 1.8.0 build 1; http://www.completegenomics.
com/sequence-data/cgatools/) and TIBCO/Spotfire version 7.0.1
(http://spotfire.tibco.com/).
Ethics statement
Prior to our experimental onset, we obtained written informed
consent from the patient’s family and all clinical investigations
have been conducted according to the Declaration of Helsinki,
developed by The World Medical Association (WMA).
Cell culture
Primary fibroblasts: TTD218UT (TTD), TTD241HE (TTD), C4RO
(wild-type) and C5RO (wild-type), were cultured in Ham’s F10
medium (BE02-014 F, Lonza) supplemented with 10% fetal bo-
vine serum (S1810, Biowest) and 1% penicillin-streptomycin
(P0781, Sigma-Aldrich) at 37 C, 20% O2 and 5% CO2.
SV40-immortalized human fibroblasts: TTD218UT-sv (TTD),
TTD218UT-sv stably expressing TFIIEbWT-GFP, MRC5_sv (wild-
type) and C5RO_sv (wild-type), were cultured in a 1: 1 mixture of
DMEM (BE12-604 F/U1) and Ham’s F10 medium (BE02-014 F,
Lonza) supplemented with 10% fetal bovine serum (S1810,
Biowest) and 1% penicillin-streptomycin (P0781, Sigma-Aldrich)
at 37 C, 20% O2 and 5% CO2.
Human iPS cells: were cultured feeder free in E8 medium
(Thermo Fisher Scientific), on matrigel (BD-biosciences)-coated
plates. Medium was changed every other day and cells were
passaged every 4–5 days, using ReLeSR (Stem cell technologies)
as described by manufacturers with a split-ratio of 1: 20. iPS
were differentiated as whole colonies derived from single cells
(28). In short, iPS were made into single cells using TrypLselect
(Lifetech) and 100–150 cells were plated onto 6 cm dishes.
Colonies were allowed to expand to 400lm size upon which me-
dia was changed to differentiation media containing 20 ng/ml
BMP4, 40 ng/ml VEGF and 50 ng/ml bFGF in Stemline II (sigma-
aldrich), media was refreshed after 3 days. At day 6, this medium
was replaced by serum- free humanized IMDM-based medium
(Cellquin) (37) supplemented with 1 lg/ml interleukin 3, 10 lg/ml
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interleukin 6, 100 ng/ml SCF, 25 ng/ml Nplate (TPO agonist),
40 ng/ml VEGF, 20 ng/ml BMP4 and 1 U/ml Erythropoietin.
Cells were refreshed every 2 days and erythroid progenitors har-
vested between day 9 and 15 were cultured as described before
in (28).
Antibodies
Primary antibodies used: a-TFIIEb (ab187143; Abcam), a-TFIIEa
(H00002960-B01, Abnova), a-TFIIEa (#1G6; gift from J.M. Egly), a-
XPB (sc-293, Santa Cruz Biotechnology), a-GFP (ab290, Abcam)
and a-Tubulin (T5168, Sigma-Aldrich).
Secondary antibodies used: CF770 anti-rabbit (SAB4600215,
Sigma-Aldrich), CF680 anti-mouse (SAB4600199, Sigma-Aldrich),
IRDye 800CW Donkey anti-mouse (926-32212, LI-COR), Alexa
Fluor 555 goat anti-mouse (A21424, Invitrogen), Alexa Fluor 555
goat anti-rabbit (A21429, Invitrogen) and Alexa Fluor 488 goat
anti-rabbit (A11034, Invitrogen), a-CD71 (Miltenyi Biotech), a-
CD235 (BD Biosciences).
Western blot analysis
Whole cell extracts were prepared by direct lysis of isolated cell
pellets in SDS–PAGE protein sample buffer reagent, separated
on 8% SDS-PAGE gel, blotted onto Immobilon-FL membrane
(IPFL00010, Merck Millipore Ltd.), stained with specific primary
and secondary antibodies and analyzed using an Odyssey im-
ager (LI-COR).
Protein stability
Cells were plated on 6 cm dishes and incubated overnight under
normal culture conditions. Cells were treated with 100 mM
Cycloheximide (CHX) and harvested at different time-points (0,
4, 8, 12, 16 and 24 h) after treatment. Whole-cell extracts were
obtained by direct lysis in sample buffer. The signal intensities
were measured and normalized to Tubulin. Signal intensities
were plotted as the percentage of TFIIEb levels after CHX treat-
ment compared with the signal intensities of the non-treated
samples (set at 100%).
Colony-forming ability/survival
Cells were plated on 10 cm dishes (1500 cells/dish, 40 C sur-
vival), in triplicate. After 24 h, cells were continuously incubated
at 37 C or 40 C for approximately 2 weeks. Colonies were fixed
and stained with 0.1% Brilliant Blue R (Sigma) and counted
(Gelcount, Oxford Optronix Ltd.). The survival was plotted as
the percentage of colonies obtained after treatment compared
with the mean number of colonies from the mock-treated cells
(set at 100%).
Transcription capacity measured by EU incorporation
Cells were grown onto 24 mm cover slip and cultured for 1 day
prior to the experiments. The cells were washed once with PBS
and incubated for 2 h in culture medium containing 100 lM
5-ethynyl-uridine (EU). After EU incorporation, cells were fixed
in 4% formaldehyde/PBS, washed twice with 3% BSA/PBS, per-
meabilized for 20 min in 0.5% Triton/PBS and washed once with
PBS. Cells were incubated for 30 min with fluorescent dye cou-
pling buffer containing 10 mM CuSO4 and Alexa Fluor 594 azide
(Click-iT, Thermo Fisher Scientific). After washing with PBS,
cells were mounted in vectashield, containing 1.5 lg/ml DAPI.
The mean fluorescence is determined with a confocal micro-
scope (Zeiss LSM 700) from at least 50 cells. Images were pro-
cessed using ImageJ and the average fluorescence intensity in
the nucleus of MRC5_sv wild-type cells was set at 100%.
Immuno fluorescence
Cells were grown on glass cover slips (24 mm) for 1 day prior to
the experiments and washed with PBS, fixed with 2% parafor-
maldehyde for 15 min, washed with PBS, washed 2 times 10 min
with 0.1% Triton X-100/PBS and incubated for 15 min with
PBSþ (PBS containing 0.15% glycine and 1% BSA). Cells were in-
cubated overnight at 4 C with primary antibodies in a moist
chamber. The next day, cover slips were washed 2 times 10 min
with PBS/Triton X-100 and washed once with PBSþ. Cells were
incubated for 1 h with secondary antibodies at room tempera-
ture in moist chamber and again washed three times in PBS/
Triton X-100. Samples were embedded in Vectashield mounting
medium (Vector Laboratories, containing 1.5 lg/ml DAPI). The
mean fluorescence is determined with a confocal microscope
(Zeiss LSM 700) from at least 50 cells. Images were processed us-
ing ImageJ.
Generation of human iPS cells
Primary fibroblasts from patient TTD218UT and control fibro-
blasts were reprogrammed through lentiviral transduction of
human genes OCT4, SOX2, c-MYC and KLF4, using engineered
color-coded lentiviral vectors (27).
Flow cytometry
Cells were washed once in PBS, resuspended in PBS with 0.5%
BSA and stained with appropriate antibodies for 1 h as indicated
in the figure legends. Cells were washed in PBS and flow cytom-
etry experiments were performed with BD FACS CantoII or BD
LSRIIþHTS (BD Bioscsiences, Franklin Lakes, NJ). The data were
analyzed with FACSDiva Software (BD Biosciences, Franklin
Lakes, NJ) and FlowJo Software (Tree Star, Ashland, OR).
Cytospin preparation
Cells (5 105) were cytospun onto glass slides, fixed in metha-
nol, and stained with benzidine to visualize haemoglobin and
DIFCO B/C. Images were taken with a Zeiss Axioscope A1 macro-
scope (50x lens) and processed using Adobe Photoshop 9.0
(Adobe Systems Inc.; CA, USA).
HPLC to detect hemoglobin variants
Separation of the various Hb fractions was performed by high-
performance cation-exchange liquid chromatography (CE-
HPLC) on Waters Alliance 2690 equipment (Waters, Milford, MA,
USA) according to (31). In short, the protocol consisted of a 30-
min elution over a combined 20–200 mM NaCl and pH 7.0–6.6
gradient in 20 mM BisTris/HCl, 2 mM KCN. The column, a
PolyCAT A 100/4.6-mm, 3 lm, 1500 A˚ column, was purchased
from PolyLC (Columbia, MD, USA).
Supplementary Material
Supplementary Material is available at HMG online.
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